Carriership of the factor V (FV) gene marked by the R2-haplotype, a series
of linked polymorphisms encoding several amino acid changes in FV, is assoc
iated with mild resistance to activated protein C (APC) and with an increas
ed risk of thrombosis. We compared the functional properties of normal FV(a
) and R2-FV(a) in model systems and in plasma. FV and R2-FV were equally we
ll activated by thrombin and expressed identical cofactor activities in pro
thrombin activation. Rate constants of APC-catalyzed inactivation of FVa an
d R2-FVa were similar both with and without protein S. However, significant
differences were observed between haemostatic parameters determined in pla
sma from homozygous carriers of the R2-gene (n = 5) and age-matched non-car
riers (n = 19). Plasma from R2-carriers contained significantly lower FV le
vels and the ratio of the two FV isoforms (FV1 and FV2) was shifted in favo
r of FV1. The FV2/FV1 ratio was 1.4 (95% CI = 1.3-1.5) in homozygous carrie
rs of R2 and 2.8 (95% CI = 2.5-3.1) in controls (p <0.00001). In an APC res
istance test which quantifies the cofactor activity of FV in APC-catalyzed
FVIII(a) inactivation, homozygous R2-carriers had significantly lower (p <0
.00001) APC sensitivity ratios (APCsr = 1.54, 95% CI = 1.48-1.60) than cont
rols (APCsr = 2.17, 95% CI = 2.05-2.28). This indicates that R2-FV has redu
ced cofactor activity in APC-catalyzed FVIII(a) inactivation. The changes o
f the relative amounts of FV1 and FV2 in carriers of the R2-gene will resul
t in increased thrombin formation in the presence of APC and may provide a
mechanistic explanation for the increased thrombotic risk associated with t
he R2-haplotype.